ConductScience.org, home

Paper339802

Hormonal therapy of breast cancer: new approaches and concepts.

Legha SS and 2 others. Ann Intern Med, 1978. Cited by 128 papers, by iCite.

Cite this record

ConductScience Library. Hormonal therapy of breast cancer: new approaches and concepts. Papers, record 339802. Release papers-2026-11-12-0.1.0, 12 Nov 2026. https://conductscience.org/library/papers/339802

Download JSON
Sources
11 sources
Release
papers-2026-11-12-0.1.0

Paper

PubMed's record of the paper, with iCite's citation figures. No abstract is shown.

Title
Hormonal therapy of breast cancer: new approaches and concepts.
PubMed
Journal
Ann Intern Med
PubMed
Year
1978
PubMed
Publication types
Journal Article, Review
PubMed
Citations, by iCite
128
iCite
Relative citation ratio, by iCite
4.92
iCite
Revised in PubMed
2019-06-19
PubMed

Authors3

The authors in the order PubMed's record lists them, with the ORCID iDs it states.

OrderAuthorForenameKindORCID iD
1Legha SSS S
2Davis HLH L
3Muggia FMF M

Source PubMed

Download CSV of authors

Topics15

NLM's MeSH indexing of the paper, its major topics first.

MeSH termMajor
Breast NeoplasmsMajor topic
Estrogen AntagonistsMajor topic
Adrenalectomy
Castration
Clomiphene
Ergotamines
Female
Humans
Hypophysectomy
Levodopa
Nafoxidine
Neoplasm Metastasis
Prolactin
Receptors, Estrogen
Tamoxifen

Source PubMed

Download CSV of topics

Cited by17

The papers in our copy of PubMed whose reference list names this one, newest first. iCite, which reads more sources, counts 128 citations.

PMIDTitleJournalYearIn PapersSource
37190134Breast Cancer: Impact of New Treatments?Cancers (Basel)2023https://conductscience.org/library/papers/37190134PubMed
36291916Anti-Hormonal Therapy in Breast Cancer and Its Effect on the Blood-Brain Barrier.Cancers (Basel)2022https://conductscience.org/library/papers/36291916PubMed
35159024Hormonal Therapy for Gynecological Cancers: How Far Has Science Progressed toward Clinical Applications?Cancers (Basel)2022https://conductscience.org/library/papers/35159024PubMed
16622738Tamoxifen flare hypercalcemia: an additional support for gallium nitrate usage.J Bone Miner Metab2006https://conductscience.org/library/papers/16622738PubMed
6953448Abnormal oxidative metabolism of estradiol in women with breast cancer.Proc Natl Acad Sci U S A1982https://conductscience.org/library/papers/6953448PubMed
6814594Choosing treatment for metastatic breast cancer.Br Med J (Clin Res Ed)1982https://conductscience.org/library/papers/6814594PubMed
6802332Tamoxifen as initial sole treatment of localised breast cancer in elderly women: a pilot study.Br Med J (Clin Res Ed)1982https://conductscience.org/library/papers/6802332PubMed
6293630A phase II trial of tamoxifen, premarin, methotrexate and 5-fluorouracil in metastatic breast cancer.Breast Cancer Res Treat1982https://conductscience.org/library/papers/6293630PubMed
3766307Effect of in vivo antiestrogen pretreatment on rabbit atrial chronotropic response to histamine.Agents Actions1986https://conductscience.org/library/papers/3766307PubMed
3224082Epidermal growth factor receptor (EGFr) status associated with failure of primary endocrine therapy in elderly postmenopausal patients with breast cancer.Br J Cancer1988https://conductscience.org/library/papers/3224082PubMed
2149280Phase I study of the tolerance and pharmacokinetics of toremifene in patients with cancer.Breast Cancer Res Treat1990https://conductscience.org/library/papers/2149280PubMed
1534019Comparison of two oestrogen receptor assays in the prediction of the clinical course of patients with advanced breast cancer.Br J Cancer1992https://conductscience.org/library/papers/1534019PubMed
1391980Tamoxifen metabolism is altered by simultaneous administration of medroxyprogesterone acetate in breast cancer patients.Breast Cancer Res Treat1992https://conductscience.org/library/papers/1391980PubMed
421034Age and death in breast cancer.Br Med J1979https://conductscience.org/library/papers/421034PubMed
363401Drug treatment of breast cancer.Drugs1978https://conductscience.org/library/papers/363401PubMed
352663Tamoxifen: a review of its pharmacological properties and therapeutic use in the treatment of breast cancer.Drugs1978https://conductscience.org/library/papers/352663PubMed
208709Hormone receptors in breast cancer.Br Med J1978https://conductscience.org/library/papers/208709PubMed

Download CSV of cited by

Genes1

The genes the Gene search release ties to the paper: Swiss-Prot's references first, then PubTator's text mining.

GeneNCBI Gene IDLinked byIn Genes
ESR12099PubTator's text mininghttps://conductscience.org/library/genes/2099

Source NCBI Gene

Download CSV of genes

Data dates

The date of each source this release read.

PubMed
2026-11-06
PubMed
iCite
2026-11-05
iCite
PMC's ID file
2026-11-05
PMC's ID file
NIH RePORTER's grant and paper links
2026-11-01
NIH RePORTER's grant and paper links
Trials
2026-11-12
Gene search
2026-11-11
Pipelines
2026-09-18

None in this release

  • Grants
  • Trials
  • Comments and corrections
  • References
  • Drugs
  • Data

Sources 11

  • ChEMBL, through Open TargetsCC BY-SA 3.0
  • ClinicalTrials.govNo license stated
  • HGNCCC0
  • iCiteCC BY 4.0
  • NCBI GenePublic domain (US government)
  • NIH RePORTER's grant and paper linksPublic domain
  • Open TargetsCC0 1.0
  • PMC's ID filePublic domain (US government)
  • PubMedNLM's terms
  • PubTator 3Public domain
  • UniProtCC BY 4.0
Each source's terms
  • ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
  • ClinicalTrials.govnone stated
  • HGNCCC0: https://www.genenames.org/about/license/
  • iCiteCC BY 4.0
  • NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
  • NIH RePORTER's grant and paper linksPublic domain (NIH RePORTER)
  • Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
  • PMC's ID fileNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
  • PubMedNLM's terms
  • PubTator 3Public domain
  • UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license

ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.

For software

Read this paper from software.

The record and each of its lists are JSON, twenty rows a page. No key.

GET https://conductscience.org/api/papers/v1/339802

GET https://conductscience.org/api/papers/v1/339802/authors